ELI LILLY & Co
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3025% above fair value
$1410.99−6.55 (-0.46%)
Close on Nov 2, 2026Market cap $1.33TP/E 45.8Yield 0.44%
Eli Lilly Non-GAAP gross margin: $54,615M in FY2025, up 46.9% from a year earlier.
Latest, FY2025
54,615
Period ended Dec 31, 2025
Change on a year earlier
+46.9%
37,178 in FY2024
History
4 years
Since FY2022
Sources
3
Documents cited below
Where the FY2025 figure comes from
“|| Gross Margin - Non-GAAP | $ | 16,044 | $ | 11,265 | $ | 54,615 | $ | 37,178”
Source: Earnings Release (Form 8-K FY2025Q4 EX-99.1) (filed 2026-02-04) ↗
Reported in Form 8-K Earnings Releases (Non-GAAP Reconciliation Schedules).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Non-GAAP gross margin ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 54,615 | +46.9% | Earnings Release (Form 8-K FY2025Q4 EX-99.1) (filed 2026-02-04) ↗ |
| FY2024 | Dec 31, 2024 | 37,178 | +35.0% | Earnings Release (Form 8-K FY2024Q4 EX-99.1) (filed 2025-02-06) ↗ |
| FY2023 | Dec 31, 2023 | 27,548 | +22.5% | Earnings Release (Form 8-K FY2023Q4 EX-99.1) (filed 2024-02-06) ↗ |
| FY2022 | Dec 31, 2022 | 22,486 | – | Earnings Release (Form 8-K FY2023Q4 EX-99.1) (filed 2024-02-06) ↗ |
Breakdown
What makes up non-GAAP gross margin
Cite this data
StockData. (2026). Eli Lilly Non-GAAP gross margin ($M), annual FY2022–FY2025 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/gm-nongaap
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.